Article Details

Menarini Group Licenses Preclinical Oncology Asset from Insilico Medicine

Retrieved on: 2025-01-10 20:32:03

Tags for this article:

Click the tags to see associated articles and topics

Menarini Group Licenses Preclinical Oncology Asset from Insilico Medicine. View article details on hiswai:

Excerpt

“We are thrilled to enter our second collaboration with Insilico Medicine, a leader in the field of generative AI, for a highly selective and ...

Article found on: www.contractpharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up